Status:

COMPLETED

Digital App and Platform for Supporting Medicines Control and Optimization in Older Individuals With Heart Failure

Lead Sponsor:

Clinika de Kay SL

Conditions:

Heart Failure

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

The intervention being piloted in this study is a novel system of supporting older individuals (\>60 years old) with heart failure to self-manage their chronic condition through the use at home of a d...

Detailed Description

INTRODUCTION AND FINDINGS People who are aged 65 years and older account for almost a fifth of the population of the European Union. The number of people in this age group is projected to reach 151 mi...

Eligibility Criteria

Inclusion

  • Users of HUMANA GROUP
  • Aged 60 years old or older at the time of recruitment
  • Diagnosed with heart failure at stage 2-3
  • Self-reported capacity (alone or with help) to use at least 2 devices among blood pressure meter, weight scale and pulse oximeter.
  • Living at home or in sheltered apartments.
  • Self-reported capacity to consent
  • Self-reported confident user of smartphone
  • Daily access to internet
  • Access to an android smartphone, with android version greater or equal to 6

Exclusion

  • Not meeting the inclusion criteria

Key Trial Info

Start Date :

July 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 31 2023

Estimated Enrollment :

9 Patients enrolled

Trial Details

Trial ID

NCT05353803

Start Date

July 1 2022

End Date

January 31 2023

Last Update

February 8 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clínica Humana

Palma de Mallorca, Balearic Islands, Spain, 07010

Digital App and Platform for Supporting Medicines Control and Optimization in Older Individuals With Heart Failure | DecenTrialz